Comparing Treatment Patterns of Duloxetine and Venlafaxine for Depression
Author Information
Author(s): Ye Wenyu, Zhao Yang, Robinson Rebecca L, Swindle Ralph W
Primary Institution: Lilly USA, LLC
Hypothesis
Are duloxetine and venlafaxine XR interchangeable in their patterns of use for patients with major depressive disorder?
Conclusion
Patients treated with duloxetine tend to have a more complex and costly clinical presentation compared to those treated with venlafaxine XR.
Supporting Evidence
- Patients treated with duloxetine were more likely to have a history of comorbid psychiatric and nonpsychiatric conditions.
- Duloxetine initiators had higher previous health care costs compared to venlafaxine XR patients.
- Logistic regression analysis showed that 61% of patients' treatment choices could be predicted from prior characteristics.
Takeaway
This study looked at how two medications for depression are used. It found that one medication is often given to patients with more complicated health issues.
Methodology
Retrospective analysis of an administrative insurance claims database studying patients with major depressive disorder treated with duloxetine or venlafaxine XR.
Potential Biases
Potential biases may exist due to unmeasured factors and the exclusion of patients not meeting inclusion criteria.
Limitations
The study is subject to selection biases and unmeasured confounding factors due to its retrospective nature.
Participant Demographics
Patients were aged 18 to 64, with a higher proportion of females in the duloxetine group.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website